← FDA Drug Approvals (Drugs@FDA)

AVANDARYL

NDA · New Drug Application · Sponsor: SB PHARMCO · Approved 2005-11-23

Drug application

FDA Application #

NDA021700

Application type

New Drug Application

Brand name

AVANDARYL

Generic name

Glimepiride

Active ingredients

GLIMEPIRIDE; ROSIGLITAZONE MALEATE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

SB PHARMCO

First approval

2005-11-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown